Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart pump patients may get help from a surprising drug

NCT ID NCT06510322

First seen Jan 24, 2026 · Last updated May 23, 2026 · Updated 17 times

Summary

This study tests whether sildenafil (a drug often used for erectile dysfunction) can reduce blood vessel damage in people with a left ventricular assist device (LVAD), a mechanical heart pump for advanced heart failure. About 50 adults with an LVAD will receive either sildenafil or a placebo. Researchers will use ultrasound and a tiny camera pill to check for changes in blood vessel stiffness and gut bleeding spots over six months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VASCULAR DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Montefiore Medical Center

    RECRUITING

    The Bronx, New York, 10461, United States

Conditions

Explore the condition pages connected to this study.